No Data
Shanghai OPM Biosciences Co., Ltd. (SHSE:688293) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Aupu Mai (688293.SH): Shareholder Shanghai Panxin intends to collectively reduce their shareholding by no more than 3.00%.
On November 4, Gelonhui announced that Opuma (688293.SH) received a "Notice of Shareholders' Shareholding Reduction Plan" from Shanghai Panxin, a shareholder with more than 5% of the shares, on November 3, 2024. Due to the shareholder's own funding needs, Shanghai Panxin plans to reduce the company's shares through block trades and centralized competitive trading from November 26, 2024 to February 22, 2025. The total number of shares to be reduced shall not exceed 3,443,173 shares, with a total reduction ratio not exceeding 3.00% of the company's current total share capital.
Oppo Mai: Oppo Mai: third quarter report 2024
Oppo Mai: third quarter report 2024
Aupumai (688293.SH) released its performance for the first three quarters, with a net income of 27.2348 million yuan, a 36.93% year-on-year decrease.
Aupuma (688293.SH) released the third quarter report of 2024, with the company's revenue for the first three quarters at 2.1...
Aupu Mai (688293.SH): The net income for the first three quarters was 27.2348 million yuan, a year-on-year decrease of 36.93%.
On October 30, Oupumai (688293.SH) announced that in the first three quarters of 2024, it achieved total operating income of 0.216 billion yuan, a year-on-year increase of 25.73%; net income attributable to the parent company's shareholders was 27.2348 million yuan, a year-on-year decrease of 36.93%; and the basic earnings per share was 0.24 yuan.
What Shanghai OPM Biosciences Co., Ltd.'s (SHSE:688293) P/S Is Not Telling YouNo Data
No Data
